Identification of differentially regulated secretome components during skeletal myogenesis - Wikidata - awgldk - TriplyDB

Identification of differentially regulated secretome components during skeletal myogenesis

Identification of differentially regulated secretome components during skeletal myogenesis

http://www.wikidata.org/entity/Q34994347

about

The proteomic to biology inference, a frequently overlooked concern in the interpretation of proteomic data: a plea for functional validation.Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance Role of osteoglycin in the linkage between muscle and bone.Myostatin is a novel tumoral factor that induces cancer cachexia.Myocyte-derived Tnfsf14 is a survival factor necessary for myoblast differentiation and skeletal muscle regeneration Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages.The effect of palmitate supplementation on gene expression profile in proliferating myoblasts Effects of myokines on bone.Skeletal muscle as an endocrine organ: Role of [Na(+)]i/[K(+)]i-mediated excitation-transcription coupling Comparative Skeletal Muscle Proteomics Using Two-Dimensional Gel Electrophoresis.Changes in Communication between Muscle Stem Cells and their Environment with Aging.Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines.Proteomic identification of biomarkers of skeletal muscle disorders.Proteomic approach to skin regeneration in a marine teleost: modulation by oestradiol-17β.Molecular Communication from Skeletal Muscle to Bone: A Review for Muscle-Derived Myokines Regulating Bone Metabolism.Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.Differentially regulated gene expression in quiescence versus senescence and identification of ARID5A as a quiescence associated marker.Osteoglycin inhibition by microRNA miR-155 impairs myogenesis.Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal.Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells.

P2860

Q30700824-0F2FE01F-C50C-4707-9905-4FACCF99578D Q33844548-48F1E556-1570-40E4-B121-AC1B77A628F2 Q34700818-5AE8B736-4690-4C27-9339-B8458E2C3A36 Q35325687-0761A2DC-2B68-4C9B-9192-133C8EE17699 Q35874317-3BB02454-CAAF-44BB-A7EF-F98D960FE609 Q36126654-6BC0FCAA-E9E2-4733-BFDB-721A5128D642 Q36485188-AA11DB59-8D36-4D84-981F-1650CBB8C1DA Q36666383-2D0D555C-B7B9-4322-93C2-0ACA03B38D7D Q36940897-92B3B710-0D97-4C53-B8B0-2B5B517E8FDD Q37112054-FB522007-E201-4B58-A424-ADE402C7ED3F Q37234514-F55F1A80-913E-4639-88E4-A27A6811AE46 Q37566405-4F36C878-E542-435D-ACAE-F89A46FABF78 Q37589632-D88FD356-2874-4184-B93E-A06D12E9B6A2 Q37724747-9187EE57-DFB8-4339-BDA3-A39376976181 Q38079622-36081FF9-FCC1-4382-8E1B-758FCEA459FB Q38489607-4113AA5B-E8EE-43B8-85B8-E7D585CDDC42 Q39004195-88F880C3-C533-44C3-8A5B-D136AF911B70 Q39205845-6C56285C-3ECA-44D8-9B70-9446E6D4AB95 Q46327324-41304FF6-2014-4306-A4A6-632713758155 Q46845463-132EC3A7-DC8A-4C7E-98D3-D1F1DD6EF0F1 Q47157200-22AF33A6-BA92-4E57-94A5-2F34F03DC9EC Q51805303-049DEFDB-F728-45B9-97FB-CBA152103BE8 Q53809093-6C28D16D-A710-4066-8170-02870784B737

P2860

Identification of differentially regulated secretome components during skeletal myogenesis

http://www.wikidata.org/entity/Q34994347

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Identification of differential ...... nts during skeletal myogenesis

@ast

Identification of differential ...... nts during skeletal myogenesis

@en

Identification of differential ...... nts during skeletal myogenesis

@nl

type

label

Identification of differential ...... nts during skeletal myogenesis

@ast

Identification of differential ...... nts during skeletal myogenesis

@en

Identification of differential ...... nts during skeletal myogenesis

@nl

prefLabel

Identification of differential ...... nts during skeletal myogenesis

@ast

Identification of differential ...... nts during skeletal myogenesis

@en

Identification of differential ...... nts during skeletal myogenesis

@nl

P1433

Q34994347-B1D52CA4-A4C3-475E-A082-53486607BD41

P1476

Q34994347-C1C4C0BF-60CE-40D8-B157-799F83A2ACCA

P2093

Q34994347-1CC83F7D-225F-4773-AB1B-866A597B5CE1

Q34994347-2C8ACE24-B95E-4246-BE28-A73ADF3674BD

Q34994347-4A8973E1-5933-4D65-B79E-247AC64D6F9A

Q34994347-5FAE86B3-F40E-4577-A5B6-01E21C341659

Q34994347-6A80C281-E2B4-4B99-B02C-8BD30D4E8457

Q34994347-6C40A7A9-6525-4795-99C9-1084B694A255

Q34994347-751D86FC-F0C0-4E44-B657-BC50F7FA6FCB

Q34994347-83A161B8-A9D3-4C48-B403-BF949EFD14D8

Q34994347-90457C91-3B00-4D14-A440-48DC27797470

Q34994347-973BED8B-A31F-4CE0-BC5C-DB031400C2FE

P2860

Q34994347-01424E94-12E6-4B21-98A8-8F48687E011E

Q34994347-020F2A6D-2829-43AE-B0E3-459300111538

Q34994347-03139411-EF3C-4CF3-8AB4-00013116595D

Q34994347-059E6C7C-A52C-439B-8A5F-B0DA418DE76F

Q34994347-05CA4E82-FAAA-431D-9611-853755483FEE

Q34994347-06045FAB-FDB4-4823-8E37-3CDC53F9AC88

Q34994347-06250164-7A33-4DFF-9861-8E9C8E3CA367

Q34994347-07E05349-B4FE-4131-A37A-F687B0027853

Q34994347-080D6A23-7D55-47F1-B960-CF713D8B4417

Q34994347-08C8D850-9A71-4B05-BD60-11078161CBFE

P304

Q34994347-76795CBA-95B3-4B6D-8D1D-44E4CBB2B84C

P31

Q34994347-EB520655-88A3-47B7-93D6-BD6E78D0C188

P356

Q34994347-8179FB41-F394-4F2E-AA27-F5CE059BAB17

P433

Q34994347-857F2811-BC0C-4EF4-B4C5-C4FA7BAA69D0

P478

Q34994347-5FCE4E66-102D-484D-B8BC-D27767E266D2

P50

Q34994347-432154A5-C56E-4ABA-B491-036D5F9ED29D

P577

Q34994347-93DBE930-EE33-494F-8360-185E75A4E65A

P698

Q34994347-BC04FCA0-98A7-4AB2-928A-A08533B48B33

P932

Q34994347-661335AE-63C0-4D99-8564-0D4C4F4C8EDC

P356

MCP.M110.004804

P1433

Molecular & Cellular Proteomics

P1476

Identification of differential ...... nts during skeletal myogenesis

@en

P2093

C Y X'avia Chan

http://www.w3.org/2001/XMLSchema#string

Dharsee Moyez

http://www.w3.org/2001/XMLSchema#string

Jian Chen

http://www.w3.org/2001/XMLSchema#string

John C McDermott

http://www.w3.org/2001/XMLSchema#string

K W Michael Siu

http://www.w3.org/2001/XMLSchema#string

Kenneth R Evans

http://www.w3.org/2001/XMLSchema#string

Olena Masui

http://www.w3.org/2001/XMLSchema#string

Olga Krakovska

http://www.w3.org/2001/XMLSchema#string

Peihong Zhu

http://www.w3.org/2001/XMLSchema#string

Shaun Ghanny

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm

Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis

A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo

Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression, and mapping of the gene on human and mouse chromosomes

A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts

Phosphorylation of nuclear MyoD is required for its rapid degradation.

A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1

The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity

Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

P304

M110.004804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M110.004804

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Sebastien Voisin

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21343469

http://www.w3.org/2001/XMLSchema#string

P932

3098588

http://www.w3.org/2001/XMLSchema#string